Equity

Key Financial Ratios Home > Equity > Corporate Information > Key Financial Ratios

ERIS Lifesciences LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:540596 P/E (TTM) :80.43
ISIN Demat:INE406M01024 Div & Yield %:0.44 EPS (TTM) :20.69
Book Value (RS) :203.3941378 Market Cap (Rs Cr.):22667.85 Face Value (RS) :1
    Change Company 
YearsMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Debt-Equity Ratio0.960.610.080.000.00
Long Term Debt-Equity Ratio0.430.150.050.000.00
Current Ratio0.961.152.542.862.73
Fixed Assets0.731.051.431.631.57
Inventory12.0519.6818.0516.2517.02
Debtors7.166.517.319.678.71
Interest Cover Ratio1.556.7322.00151.34414.72
PBIDTM (%)30.6431.9738.9742.2038.55
PBITM (%)19.9725.2734.1537.9735.16
PBDTM (%)17.7128.2237.4241.9538.47
CPM (%)15.2126.3134.5238.5535.01
APATM (%)4.5419.6129.6934.3231.62
ROCE (%)6.839.9719.9425.6826.48
RONW (%)3.0712.6319.2323.8824.39

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)